EXPRESS: Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial

More on APOE

• Rapamycin improves efferocytosis and reduces plaques in mice

  International Immunopharmacology · 3 Oct 2026

  

• Smoking links to dementia risk mainly in APOE ε4 noncarriers

  Biological Psychiatry Global Open Science · 4 Oct 2026

  

• Disadvantaged neighborhoods tie to lower brain vascular function

  Cerebral Circulation - Cognition and Behavior · 4 Oct 2026

  

• APOE4 alters olfactory neurons across age and sex in mice

  bioRxiv · 4 Oct 2026